Skip to content
Open access

Body mass index outperforms the Rotterdam criteria in defining phenotypic heterogeneity in polycystic ovary syndrome: a multicenter study from the Italian PCOS registry (PCOSOUTCOME.net)

Aug 2026 · Journal of Endocrinological Investigation · Vol 49, pp. 2813 - 2823 · 0 citations · 37 references
Medicine

TL;DR

In this multicenter cohort, Rotterdam phenotypes failed to discriminate metabolic risk, whereas BMI-based stratification proved more informative in identifying cardiometabolic complications.

Abstract

Polycystic ovary syndrome (PCOS) is a common and highly heterogeneous endocrine–metabolic disorder. The Rotterdam criteria identify four diagnostic phenotypes; however, it remains unclear whether these phenotypes or body mass index (BMI) better predict metabolic risk. The PCOSOUTCOME.net registry collects data from multiple Italian centers and provides an opportunity to compare the effectiveness of Rotterdam phenotypes versus BMI in characterizing the clinical, metabolic, and psychological heterogeneity of women with PCOS. We included 1,314 Caucasian women of reproductive age with PCOS. Participants were stratified according to Rotterdam phenotypes and BMI categories (normal weight, overweight, and obesity; and BMI < 27 kg/m² vs. ≥ 27 kg/m²). Clinical, hormonal, metabolic, gynecological, and psychological parameters were assessed and compared across subgroups. No significant differences in BMI or in the prevalence of metabolic complications (dyslipidemia, glucose intolerance, hypertension, and metabolic syndrome) were observed among the four Rotterdam phenotypes, although anxiety scores were highest in phenotype A. In contrast, BMI-based stratification identified clear differences in metabolic markers: women with obesity or a BMI ≥ 27 kg/m² showed a higher prevalence of all metabolic complications, as well as higher free androgen index (FAI) and hirsutism scores. In this multicenter cohort, Rotterdam phenotypes failed to discriminate metabolic risk, whereas BMI-based stratification proved more informative in identifying cardiometabolic complications. Moreover, obesity in PCOS identifies a distinct hyperandrogenic phenotype. These findings underscore the need to integrate BMI into the classification of PCOS to better capture patient heterogeneity, with potential implications for metabolic assessment and risk stratification.

Read PDF

Similar papers

Open access Sep 2026

Phenotype-Specific Differences in Insulin Resistance and Androgenic Profiles in Polycystic Ovary Syndrome: A Prospective Observational Study

Background and Objectives: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder characterized by distinct phenotypic presentations. This study aimed to compare androgenic and metabolic characteristics across Rotterdam-defined PCOS phenotypes, with particular emphasis on insulin resistanc...

Karolin Ohanoglu Cetinel, Ahmet Cinar, Can Tercan et al. · 0 citations
Review Open access Oct 2026

Comparison of Clinical, Metabolic, and Hormonal Profiles in Obese Versus Lean Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis

Obese PCOS is associated with more severe reproductive, metabolic, and hormonal abnormalities, but lean PCOS still carries substantial reproductive and metabolic burdens, and substantial heterogeneity across several outcomes warrant cautious interpretation.

F. Aalpona, Apurba Sarker, Lutfun Nahar et al. · 0 citations
Open access Sep 2026

Association of prolactin with cardiometabolic risk markers in women with polycystic ovary syndrome: a phenotype-based analysis

Compared with controls, women with PCOS had higher body weight, body-mass index, waist circumference, waist circumference, triglyceride levels, insulin resistance-related parameters, triglyceride-glucose (TyG) Index, lipid accumulation product (LAP), and Atherogenic Index of Plasma (AIP), whereas high-density lipoprote...

Hatice Çalışkan Burgucu, Emel Yılmaz Kaya, Ayşen Yümlü et al. · 0 citations
Open access Oct 2026

Cardiovascular risk in under-represented minority women with PCOS: evidence for subclinical cardiac remodeling and HFpEF predisposition

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in reproductive-aged Hispanic and South Asian women. PCOS is associated with higher rates of morbid obesity and insulin resistance which may lead to cardiovascular disease (CVD). The most recent JACC Scientific Statement on HFpEF does not id...

J. Guardia, H. Bonilla, K. Jafri et al. · 0 citations
Open access Sep 2026

The Impact of Phenotypes, Body Mass Index, and Hyperandrogenism on Depression and Body Image in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study

AIM: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in women of reproductive age that threatens not only physical but also psychosocial health. It is well-documented that the visible manifestations of high body mass index (BMI) and hyperandrogenism negatively affect body image and increase the risk...

Büşra Hüsam Konan, Yusuf Ustun · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.